How did ASX-listed stocks CM8, GPT, ZNO fare in March 2021 quarter?


  • Australia is making progress towards economic recovery to get people back to work.
  • Crowd Media Holdings marked the March quarter with the first SaaS licence signed for its AI platform.
  • GPT Group highlighted that the economic recovery helped strengthen the operating environment. The Company reported high net billing collections across portfolios.
  • Zoono indicated that its Microbe Shield was successfully tested in the US. The Company also hired new distribution partners and partnered with Microsoft.

The Australian economy seems to be moving in the right direction, with multiple businesses playing a pivotal role in getting people back to work.

DO WATCH: The Economic Corner: Can the Australian economy grow this year at its fastest pace since 2007?

Several ASX-listed companies have released their quarterly updates indicating decent performance, in general, during the period.

Some of the companies that have recently announced their quarterly reports include Megaport Limited (ASX:MP1), Life360 Inc.(ASX:360) and Pointerra Limited (ASX:3DP).     

This article will take you through three firms that announced their results today – Crowd Media, GPT Group and Zoono.

Source: © Charlieaja|

Crowd Media Holdings Limited (ASX:CM8)

Crowd Media Holdings Limited uses its Artificial Intelligence platform for conversational commerce applications.

In its Q3 FY2021 results, the Company highlighted an improvement in operating cash flow from -AU$0.7 million to AU$0.3 million, up 148% QoQ. Other key highlights from the period are highlighted below:

  • It signed its first SaaS licence for its Conversation AI platform for AU$300,000 during this period.
  • Beta version of Digital Dom was launched during the quarter.
  • Crowd Media completed its first tranche of investment of US$159K (AU$204K) of the total US$250K into a joint venture (JV) with Israeli-based VFR Assets and Holdings Ltd.
  • CM8 also completed its first tranche investment of GBP 250K (AU$444K) with Aflorithmic Labs Ltd.
  • CM8's Mobile Subscription unit continues to provide constant profits.

CM8 signed its first SaaS license in the March quarter (Source: © Wrightstudio |

ALSO READ: Crowd Media (ASX:CM8) Shares Slipped Over 13.5% Following Its Latest Updates

Financial highlights

By the end of Q3 FY2021, the Company reported an increase in the cash balance by AU$1.3 million to AU$4.2 million.

  • Net cash from operating activities increased by 148% to AU$319K, reflecting net trading receipts of AU$122K and a tax refund received of AU$438K.
  • Net cash flow from investing activities was AU$877K.
  • CM8 raised AU$1.4 million via placement in January 2021 and got AU$0.8 million from the exercise of options. It used AU$176K to reduce its lease liabilities.

CM8 shares ended the day in line with the previous close at AU$0.034.

INTERESTING READ: Do You Know These Prominent ASX-Listed Penny Stocks?


One of Australia's largest diversified property groups, GPT Group, highlighted that its diversified portfolio benefitted from the ongoing economic recovery. The Company reported that in logistics, tenant demand for high-quality assets remained strong aiding the ongoing rollout of its development pipeline. Leasing activity in the office sector continued to improve as businesses prepare themselves for the recovering economy. The retail sales momentum was supported by jobs growth and strong consumer confidence.

Q3 Highlights

  • Rent collection rates were 105% of net billings.
  • Office portfolio occupancy decreased from 94.9% during December 2020 quarter to 91.9% post the completion of 32 Smith, Parramatta.
  • Logistics portfolio occupancy dropped from 99.8% as on 31 December 202o to 96.8% as on 31 March 2021 post the lease expiry in Melbourne. By 31 March 2021, the Company completed logistics leasing of 51,300 m2.
  • Retail Total Specialty sales increased by 8%.
  • GPT bought back AU$111.8 million of securities at an average of AU$4.52 per security on 28 April 2021.

GPT shares closed at AU$4.670, down 0.639%.

ALSO READ: GPT Group lifts dividend guidance for 2021

Zoono Group Limited (ASX:ZNO)

Global biotech company Zoono Group Limited has released its Q3 FY2021 results for the quarter ended 31 March 2021.

Zoono Group made significant developments during Q3 and also provided its outlook for the final quarter of FY21. Key highlights from the quarter are mentioned below:

Q3 Highlights

  • Zoono Microbe Shield proved effective against Human Coronavirus 229E. The test was carried out in the US.
  • Post the regulatory consents, ZNO hired new distribution partners in Luxembourg, Norway, Poland, and Poland. In Russia, the initial orders for the Company’s products have been shipped.
  • Technology giant Microsoft entered into a partnership with Zoono for its broad office network. The initial roll-out would start at Microsoft's Redmond campus and extend to other US places when staff return to the office in May.
  • ZNO also partnered with Boeing to offer its products to airlines worldwide.
  • In Europe, the Company's product is already in use on the Paris Metro.
  • Fine Hygienic Paper LLC on track to achieve US$7 million in sales over the upcoming six months.

Financial Highlights

  • In Q3, the sales stood at NZ$6.4 million. The sales revenue for FY021 till 29 April 2021 reached NZ$20.8 million.
  • Cash and cash equivalent by the closure of Q3 FY2021 stood at NZ$6.841 million.

ZNO shares closed 12.808% lower at AU$0.885.

Do READ: All You Need To Know About Zoono’s (ASX:ZNO) Achievements In Q2 FY2021





Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK